skip to Global Navigation Bar skip to main content

homeHome > Press Release > News


News Content
Daewoong Pharmaceuticals’ Zemiglo increases quarterly sales by twofold compared to last year
Date 2016-05-26 Hit 3380
News List
Prev Daewoong Pharmaceuticals proves fatigue recovery effect of Ursa through clinical trial
Next Daewoong Pharmaceuticals holds a symposium to promote the excellence of Olmesartan medications including ‘Olmetec’ at International Society of Hypertension